March of Dimes, a nonprofit organization focused on maternal and infant health, is marking the third anniversary of its Innovation Fund, which has invested in six companies addressing maternal and infant health challenges since launching in 2022.
“The Innovation Fund was born out of necessity,” said Cindy Rahman, President and CEO of March of Dimes. “Too many moms and babies face preventable risks during pregnancy, birth, and beyond. Thanks to the generosity of our donors, we are supporting entrepreneurs and scientists with bold ideas, delivering real-world solutions that save lives and strengthen families. Three years in, we’re already seeing the impact our investments have made on care delivery and outcomes.”
The fund’s portfolio includes Raydiant Oximetry, which is developing technology to monitor fetal oxygenation and address postpartum hemorrhage; PyrAmes, which created a non-invasive wearable for continuous blood pressure monitoring in newborns; Seven Starling, which offers virtual therapy and medication support for perinatal mood and anxiety disorders; Novocuff, which is advancing a cervical device for women experiencing preterm premature rupture of membranes; Millie, which provides hybrid maternity care through midwifery clinics and a virtual platform; and Iron Health, which offers integrated primary care and behavioral health services extending OB/GYN care.
Several portfolio companies are already on the market, while others are continuing development and seeking FDA approval.
The Innovation Fund is supported by philanthropic contributions and guided by an Investment Committee including Fred Goltz, Emma Goltz, and Dana Martin, and a Medical & Science Committee including Dr. George Saade, Dr. Elizabeth Howell, Dr. Irina Burd, Dr. Rashmin Savani, and Dr. Emin Maltepe.
The United States has among the highest rates of maternal mortality and preterm birth among developed countries. March of Dimes collaborates with other impact-driven venture funds and partners with nonprofit and government organizations to support maternal and infant health innovation.
